Business Context and Reporting Period
This Form 8-K is a Current Report filed by KindlyMD, Inc. (the "Company") on June 18, 2025. The filing serves to disclose a material corporate event under Item 7.01 (Regulation FD Disclosure). The Company is an emerging growth company with its principal executive offices in Salt Lake City, Utah. Its common stock (NAKA) and warrants (NAKAW) trade on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel appointment and does not contain financial statements or performance data.
Material Changes
The primary material change disclosed is a leadership appointment:
- Personnel Change: Tyler Evans has been appointed as the Chief Investment Officer at Nakamoto Holdings, Inc. ("Nakamoto").
- Relationship: The press release was issued jointly by Nakamoto and KindlyMD, Inc., indicating a strategic relationship or shared governance structure between the entities.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, outlook, or management commentary regarding future performance. No new risks, contingencies, or unusual items are detailed in the text of this report. The disclosure is limited to the announcement of the executive appointment.
Investor Verification Checklist
- Verify the exact nature of the relationship between KindlyMD, Inc. and Nakamoto Holdings, Inc. to understand the scope of the CIO appointment.
- Review the attached Exhibit 99.1 (Press Release) for details on Tyler Evans' background and specific responsibilities.
- Confirm if this appointment signals a strategic shift in investment focus for either entity.
- Note that this filing does not update financial performance; refer to the most recent 10-Q or 10-K for financial data.